Annual Total Assets
$1.49 B
-$54.43 M-3.52%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual total assets is $1.49 billion, with the most recent change of -$54.43 million (-3.52%) on December 31, 2023.
- During the last 3 years, RARE annual total assets has fallen by -$268.54 million (-15.26%).
- RARE annual total assets is now -15.26% below its all-time high of $1.76 billion, reached on December 31, 2020.
Performance
RARE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$1.54 B
-$80.07 M-4.95%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly total assets is $1.54 billion, with the most recent change of -$80.07 million (-4.95%) on September 30, 2024.
- Over the past year, RARE quarterly total assets has increased by +$300.22 million (+24.25%).
- RARE quarterly total assets is now -12.57% below its all-time high of $1.76 billion, reached on December 31, 2020.
Performance
RARE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RARE Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | +24.3% |
| 3 y3 years | -15.3% | +3.6% |
| 5 y5 years | +107.2% | +74.8% |
RARE Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | at low | -5.0% | +24.3% |
| 5 y | 5-year | -15.3% | +31.3% | -12.6% | +35.5% |
| alltime | all time | -15.3% | >+9999.0% | -12.6% | +2479.0% |
Ultragenyx Pharmaceutical Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.54 B(-4.9%) |
| Jun 2024 | - | $1.62 B(+23.8%) |
| Mar 2024 | - | $1.31 B(-12.3%) |
| Dec 2023 | $1.49 B(-3.5%) | $1.49 B(+20.4%) |
| Sep 2023 | - | $1.24 B(-5.6%) |
| Jun 2023 | - | $1.31 B(-5.2%) |
| Mar 2023 | - | $1.38 B(-10.5%) |
| Dec 2022 | $1.55 B(+1.5%) | $1.55 B(-4.5%) |
| Sep 2022 | - | $1.62 B(+22.6%) |
| Jun 2022 | - | $1.32 B(-4.6%) |
| Mar 2022 | - | $1.38 B(-9.1%) |
| Dec 2021 | $1.52 B(-13.5%) | $1.52 B(+2.5%) |
| Sep 2021 | - | $1.48 B(-1.8%) |
| Jun 2021 | - | $1.51 B(-5.3%) |
| Mar 2021 | - | $1.60 B(-9.2%) |
| Dec 2020 | $1.76 B(+55.0%) | $1.76 B(+38.7%) |
| Sep 2020 | - | $1.27 B(-3.5%) |
| Jun 2020 | - | $1.31 B(+6.6%) |
| Mar 2020 | - | $1.23 B(+8.6%) |
| Dec 2019 | $1.14 B(+57.8%) | $1.14 B(+29.0%) |
| Sep 2019 | - | $879.94 M(-8.2%) |
| Jun 2019 | - | $958.93 M(-4.8%) |
| Mar 2019 | - | $1.01 B(+40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $719.56 M(+46.6%) | $719.56 M(-6.0%) |
| Sep 2018 | - | $765.14 M(-5.1%) |
| Jun 2018 | - | $806.02 M(-1.4%) |
| Mar 2018 | - | $817.35 M(+66.6%) |
| Dec 2017 | $490.75 M(-9.2%) | $490.75 M(+12.8%) |
| Sep 2017 | - | $435.05 M(-12.6%) |
| Jun 2017 | - | $497.54 M(-8.8%) |
| Mar 2017 | - | $545.82 M(+1.0%) |
| Dec 2016 | $540.63 M(-3.4%) | $540.63 M(+4.9%) |
| Sep 2016 | - | $515.17 M(+6.9%) |
| Jun 2016 | - | $481.95 M(-8.1%) |
| Mar 2016 | - | $524.18 M(-6.3%) |
| Dec 2015 | $559.57 M(+182.7%) | $559.57 M(-7.1%) |
| Sep 2015 | - | $602.13 M(+75.5%) |
| Jun 2015 | - | $343.00 M(-3.6%) |
| Mar 2015 | - | $355.84 M(+79.7%) |
| Dec 2014 | $197.97 M(+231.9%) | $197.97 M(-6.1%) |
| Sep 2014 | - | $210.93 M(+29.7%) |
| Jun 2014 | - | $162.59 M(-5.9%) |
| Mar 2014 | - | $172.71 M(+189.5%) |
| Dec 2013 | $59.65 M(-32.5%) | $59.65 M(-13.0%) |
| Sep 2013 | - | $68.59 M(-22.3%) |
| Dec 2012 | $88.32 M(+628.1%) | $88.32 M |
| Dec 2011 | $12.13 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total assets?
- What is the all time high annual total assets for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual total assets year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly total assets?
- What is the all time high quarterly total assets for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly total assets year-on-year change?
What is Ultragenyx Pharmaceutical annual total assets?
The current annual total assets of RARE is $1.49 B
What is the all time high annual total assets for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total assets is $1.76 B
What is Ultragenyx Pharmaceutical annual total assets year-on-year change?
Over the past year, RARE annual total assets has changed by -$54.43 M (-3.52%)
What is Ultragenyx Pharmaceutical quarterly total assets?
The current quarterly total assets of RARE is $1.54 B
What is the all time high quarterly total assets for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total assets is $1.76 B
What is Ultragenyx Pharmaceutical quarterly total assets year-on-year change?
Over the past year, RARE quarterly total assets has changed by +$300.22 M (+24.25%)